988
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Promoter hypermethylation using 24-gene array in early head and neck cancer

Better outcome in oral than in oropharyngeal cancer

, , , , , , , , & show all
Pages 1220-1227 | Received 19 Mar 2014, Accepted 30 Jun 2014, Published online: 08 Jul 2014

References

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69 - 90; http://dx.doi.org/10.3322/caac.20107; PMID: 21296855
  • Crowe DL, Hacia JG, Hsieh CL, Sinha UK, Rice H. Molecular pathology of head and neck cancer. Histol Histopathol 2002; 17:909 - 14; PMID: 12168802
  • Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11:9 - 22; http://dx.doi.org/10.1038/nrc2982; PMID: 21160525
  • Tsai HC, Baylin SB. Cancer epigenetics: linking basic biology to clinical medicine. Cell Res 2011; 21:502 - 17; http://dx.doi.org/10.1038/cr.2011.24; PMID: 21321605
  • Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415 - 28; PMID: 12042769
  • Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6:597 - 610; http://dx.doi.org/10.1038/nrg1655; PMID: 16136652
  • Gasche JA, Goel A. Epigenetic mechanisms in oral carcinogenesis. Future Oncol 2012; 8:1407 - 25; http://dx.doi.org/10.2217/fon.12.138; PMID: 23148615
  • Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16:168 - 74; http://dx.doi.org/10.1016/S0168-9525(99)01971-X; PMID: 10729832
  • Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042 - 54; http://dx.doi.org/10.1056/NEJMra023075; PMID: 14627790
  • van Kempen PM, Noorlag R, Braunius WW, Stegeman I, Willems SM, Grolman W. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics 2014; 9:194 - 203; http://dx.doi.org/10.4161/epi.26881; PMID: 24169583
  • Demokan S, Dalay N. Role of DNA methylation in head and neck cancer. Clin Epigenetics 2011; 2:123 - 50; http://dx.doi.org/10.1007/s13148-011-0045-3; PMID: 22704334
  • Verschuur-Maes AH, de Bruin PC, van Diest PJ. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer. Breast Cancer Res Treat 2012; 136:705 - 15; http://dx.doi.org/10.1007/s10549-012-2301-4; PMID: 23104224
  • Chen K, Sawhney R, Khan M, Benninger MS, Hou Z, Sethi S, Stephen JK, Worsham MJ. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2007; 133:1131 - 8; http://dx.doi.org/10.1001/archotol.133.11.1131; PMID: 18025318
  • Yalniz Z, Demokan S, Suoglu Y, Ulusan M, Dalay N. Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer. DNA Cell Biol 2011; 30:17 - 24; http://dx.doi.org/10.1089/dna.2010.1090; PMID: 20860434
  • Sun D, Zhang Z, Van N, Huang G, Ernberg I, Hu L. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol 2007; 43:82 - 7; http://dx.doi.org/10.1016/j.oraloncology.2006.01.007; PMID: 16807071
  • Shaw RJ, Hall GL, Lowe D, Liloglou T, Field JK, Sloan P, Risk JM. The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression. Arch Otolaryngol Head Neck Surg 2008; 134:251 - 6; http://dx.doi.org/10.1001/archoto.2007.50; PMID: 18347248
  • Claus R, Wilop S, Hielscher T, Sonnet M, Dahl E, Galm O, Jost E, Plass C. A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR. Epigenetics 2012; 7:772 - 80; http://dx.doi.org/10.4161/epi.20299; PMID: 22647397
  • Hömig-Hölzel C, Savola S. Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol 2012; 21:189 - 206; http://dx.doi.org/10.1097/PDM.0b013e3182595516; PMID: 23111197
  • Stuppia L, Antonucci I, Palka G, Gatta V. Use of the MLPA Assay in the Molecular Diagnosis of Gene Copy Number Alterations in Human Genetic Diseases. Int J Mol Sci 2012; 13:3245 - 76; http://dx.doi.org/10.3390/ijms13033245; PMID: 22489151
  • Suijkerbuijk KP, Pan X, van der Wall E, van Diest PJ, Vooijs M. Comparison of different promoter methylation assays in breast cancer. Anal Cell Pathol (Amst) 2010; 33:133 - 41; PMID: 20978321
  • Leong KJ, Wei W, Tannahill LA, Caldwell GM, Jones CE, Morton DG, Matthews GM, Bach SP. Methylation profiling of rectal cancer identifies novel markers of early-stage disease. Br J Surg 2011; 98:724 - 34; http://dx.doi.org/10.1002/bjs.7422; PMID: 21360524
  • Cardoso LC, Tenorio Castaño JA, Pereira HS, Lima MA, Dos Santos AC, de Faria PS, Ferman S, Seuánez HN, Nevado JB, de Almeida JC, et al. Constitutional and somatic methylation status of DMRH19 and KvDMR in Wilms tumor patients. Genet Mol Biol 2012; 35:714 - 24; http://dx.doi.org/10.1590/S1415-47572012005000073; PMID: 23271929
  • López F, Sampedro T, Llorente JL, Domínguez F, Hermsen M, Suárez C, Alvarez-Marcos C. Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma. Oral Oncol 2014; 50:291 - 7; http://dx.doi.org/10.1016/j.oraloncology.2014.01.003; PMID: 24444674
  • Furlan D, Sahnane N, Mazzoni M, Pastorino R, Carnevali I, Stefanoli M, Ferretti A, Chiaravalli AM, La Rosa S, Capella C. Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon-rectum. Virchows Arch 2013; 462:47 - 56; http://dx.doi.org/10.1007/s00428-012-1348-2; PMID: 23224118
  • Pineda M, Mur P, Iniesta MD, Borràs E, Campos O, Vargas G, Iglesias S, Fernández A, Gruber SB, Lázaro C, et al. MLH1 methylation screening is effective in identifying epimutation carriers. Eur J Hum Genet 2012; 20:1256 - 64; http://dx.doi.org/10.1038/ejhg.2012.136; PMID: 22763379
  • Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol 2013; 31:868 - 75; http://dx.doi.org/10.1200/JCO.2012.44.4612; PMID: 23341533
  • Marsit CJ, Posner MR, McClean MD, Kelsey KT. Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma. Cancer 2008; 113:1566 - 71; http://dx.doi.org/10.1002/cncr.23770; PMID: 18711702
  • Castro M, Grau L, Puerta P, Gimenez L, Venditti J, Quadrelli S, Sánchez-Carbayo M. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med 2010; 8:86; http://dx.doi.org/10.1186/1479-5876-8-86; PMID: 20849603
  • Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61:3419 - 24; PMID: 11309302
  • Toyooka S, Maruyama R, Toyooka KO, McLerran D, Feng Z, Fukuyama Y, Virmani AK, Zochbauer-Muller S, Tsukuda K, Sugio K, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 2003; 103:153 - 60; http://dx.doi.org/10.1002/ijc.10787; PMID: 12455028
  • Lleras RA, Smith RV, Adrien LR, Schlecht NF, Burk RD, Harris TM, Childs G, Prystowsky MB, Belbin TJ. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma. Clin Cancer Res 2013; 19:5444 - 55; http://dx.doi.org/10.1158/1078-0432.CCR-12-3280; PMID: 23894057
  • Colacino JA, Dolinoy DC, Duffy SA, Sartor MA, Chepeha DB, Bradford CR, McHugh JB, Patel DA, Virani S, Walline HM, et al. Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristics. PLoS One 2013; 8:e54742; http://dx.doi.org/10.1371/journal.pone.0054742; PMID: 23358896
  • Huang KH, Huang SF, Chen IH, Liao CT, Wang HM, Hsieh LL. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma. Clin Cancer Res 2009; 15:4174 - 80; http://dx.doi.org/10.1158/1078-0432.CCR-08-2929; PMID: 19509163
  • Conacci-Sorrell M, Zhurinsky J, Ben-Ze’ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109:987 - 91; http://dx.doi.org/10.1172/JCI0215429; PMID: 11956233
  • Adachi Y, Takeuchi T, Nagayama T, Furihata M. T-cadherin modulates tumor-associated molecules in gallbladder cancer cells. Cancer Invest 2010; 28:120 - 6; http://dx.doi.org/10.3109/07357900903124472; PMID: 20121546
  • Kim WY, Lee JW, Park YA, Choi JJ, Sung CO, Song SY, Choi CH, Kim TJ, Huh SJ, Kim BG, et al. RAR-beta expression is associated with early volumetric changes to radiation therapy in cervical cancer. Gynecol Obstet Invest 2011; 71:11 - 8; http://dx.doi.org/10.1159/000320719; PMID: 21160189
  • Sanbhnani S, Yeong FM. CHFR: a key checkpoint component implicated in a wide range of cancers. Cell Mol Life Sci 2012; 69:1669 - 87; http://dx.doi.org/10.1007/s00018-011-0892-2; PMID: 22159584
  • Chow JP, Man WY, Mao M, Chen H, Cheung F, Nicholls J, Tsao SW, Li Lung M, Poon RY. PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy. Mol Cancer Ther 2013; 12:2517 - 28; http://dx.doi.org/10.1158/1535-7163.MCT-13-0010; PMID: 23979918
  • Khan K, Araki K, Wang D, Li G, Li X, Zhang J, Xu W, Hoover RK, Lauter S, O’Malley B Jr., et al. Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427. Head Neck 2010; 32:381 - 91; PMID: 19672867
  • Liu SS, Leung RC, Chan KY, Chiu PM, Cheung AN, Tam KF, Ng TY, Wong LC, Ngan HY. p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy. Clin Cancer Res 2004; 10:3309 - 16; http://dx.doi.org/10.1158/1078-0432.CCR-03-0119; PMID: 15161684
  • van Diest PJ. No consent should be needed for using leftover body material for scientific purposes. For. BMJ 2002; 325:648 - 51; http://dx.doi.org/10.1136/bmj.325.7365.648; PMID: 12242180
  • Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121:2465 - 72; http://dx.doi.org/10.1002/ijc.22980; PMID: 17680565
  • Farshadpour F, Konings S, Speel EJ, Hordijk GJ, Koole R, van Blokland M, Slootweg PJ, Kummer JA. Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study regarding Tobacco and Alcohol Consumption. Patholog Res Int. 2011;2011:806345
  • Shaw R. The epigenetics of oral cancer. Int J Oral Maxillofac Surg 2006; 35:101 - 8; http://dx.doi.org/10.1016/j.ijom.2005.06.014; PMID: 16154320
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
  • Nygren AO, Ameziane N, Duarte HM, Vijzelaar RN, Waisfisz Q, Hess CJ, Schouten JP, Errami A. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005; 33:e128; http://dx.doi.org/10.1093/nar/gni127; PMID: 16106041

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.